Insulet
PODD
#1109
Rank
$20.72 B
Marketcap
$294.35
Share price
3.82%
Change (1 day)
9.66%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: $20.72 Billion USD

As of January 2026 Insulet has a market cap of $20.72 Billion USD. This makes Insulet the world's 1109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026$20.72 B1.98%
2025$20.31 B9.25%
2024$18.59 B22.74%
2023$15.15 B-25.89%
2022$20.44 B11.42%
2021$18.35 B8.88%
2020$16.85 B57.04%
2019$10.73 B128.59%
2018$4.69 B16.93%
2017$4.01 B85.55%
2016$2.16 B0.48%
2015$2.15 B-16.96%
2014$2.59 B27.38%
2013$2.03 B98.38%
2012$1.02 B14.99%
2011$0.89 B26.71%
2010$0.70 B30.64%
2009$0.53 B172.45%
2008$0.19 B-67.12%
2007$0.60 B

End of Day market cap according to different sources

On Jan 6th, 2026 the market cap of Insulet was reported to be:

$20.70 Billion USD
by Nasdaq info icon info icon
$20.72 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ICU Medical
ICUI
$3.72 B-82.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
$1.59 B-92.30%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$27.40 B 32.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$493.39 B 2,281.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$222.39 B 973.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$128.65 B 520.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$953.86 B 4,503.59%๐Ÿ‡บ๐Ÿ‡ธ USA